Viewing Study NCT00728793


Ignite Creation Date: 2025-12-25 @ 1:12 AM
Ignite Modification Date: 2026-05-16 @ 6:24 PM
Study NCT ID: NCT00728793
Status: COMPLETED
Last Update Posted: 2018-02-22
First Post: 2008-08-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of CUDC-101 in Patients With Advanced Solid Tumors
Sponsor: Curis, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced Solid Tumors View
None EGFR View
None HDAC View
None Her2 View
None Open-Label View
None Dose-Escalation View